Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03166618 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing
A NA study, sponsored by Allergan.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03166618 is a NA study that was terminated before completion, run by Allergan. The registered enrollment target is 1 participants.
The verdict
NCT03166618, a NA study, was terminated before completion, sponsored by Allergan.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study will evaluate the safety and effectiveness of JUVÉDERM VOLUMA XC injectable gel in adult participants seeking correction of temple hollowing.
Interventions
- DEVICE Juvéderm® VOLUMA XC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-04-24 |
| Est. Completion | 2017-07-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03166618
The ClinicalTrials.gov registry entry for NCT03166618 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Juvéderm® VOLUMA XC is the first listed.
NCT03166618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03166618 about?
NCT03166618 is a clinical study titled "Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing". This study will evaluate the safety and effectiveness of JUVÉDERM VOLUMA XC injectable gel in adult participants seeking correction of temple hollowing.
What is the current status of trial NCT03166618?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2017-04-24. Estimated completion is 2017-07-21.
What interventions are being tested in trial NCT03166618?
The interventions under investigation include: Juvéderm® VOLUMA XC (DEVICE).
Who is sponsoring clinical trial NCT03166618?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.